MongoDB
MongoDB is the developer data platform company whose mission is to empower developers to create, transform, and disrupt industries by unleashing the power of software and data.
10-K, Mar 11, 2026
Source and method
In the company’s words: first descriptive sentence of 10-K Item 1, verbatim (extractive). Item 1 · Business · 10-K · 0001628280-26-016799 · filed Mar 11, 2026
Business
How does MongoDB make money?
No revenue split that adds up to total revenue.
Empty state, nothing estimated.
What is left of every $100?
Of every $100 in revenue, −$3 is net income.
Source and method
Of every $100 of revenue, FY2026.
Calculated: amount ÷ revenue × 100.
- Revenue: $2.5B
- Gross profit: $1.8B
- Operating income: −$137M
- Net income: −$71.2M
- Free cash flow: $500M
Where do customers sit?
60.8% of revenue is from Americas.
Source and method
Revenue by region, latest annual report.
10-K · 0001628280-26-016799 · XBRL revenue by region · one level, shares add up to 100.0% · derived
Calculated: share = region revenue ÷ total revenue.
In the company’s words ›
“Our developer data platform is a globally distributed operational database integrated with a set of data services that allow development teams to address the growing variety of application requirements, all in a unified and consistent user experience.”
“The foundation of our platform is the world’s leading, modern general purpose database.”
“Built on our unique document-based architecture, our database is designed to handle unstructured data and meet the needs of organizations for performance, scalability, flexibility and reliability while maintaining the strengths of relational databases.Every software application requires a database to store, organize and process data.”
Item 1 · Business · 10-K · 0001628280-26-016799 · filed Mar 11, 2026
Thesis
Why do people invest?
2 reasons in the company’s own words.
Position (in the company’s words)
“We compete in the database management software market, which is one of the largest in the software industry.”
Item 1 · Business · 10-K · 0001628280-26-016799 · filed Mar 11, 2026
R&D investment
“The increase in research and development expense was primarily driven by a $110.5 million increase in personnel costs, stock-based compensation and allocated overhead, and a $8.8 million increase in third-party infrastructure expenses to support ongoing product development and testing activities.”
Item 7 · MD&A · 10-K · 0001628280-26-016799 · filed Mar 11, 2026
Number check (R&D expense): stated $110M matches the stored change ($119M, ±10%)
R&D expense: $716M FY2026 · +20.0% vs FY2025 · Profitability charts
Source and method
Verbatim · selection. Sentences selected by rules from the 10-K and checked word for word against it; no AI summary. Not investment advice, not a recommendation, no forecast.
2 of 3 points met the selection rules (score, subject = the metric, quoted number within ±10% of the stored value).
- Subscription revenue +121%: no stored value to check the quoted number against.
KPIs
How fast is revenue growing?
Revenue grew 23% to $2.5B.
Revenue grew 30% YoY to $772M.
Source & method
- Counted
- Total revenue, as filed in 10-K / 20-F / 10-Q XBRL.
- Formulas
- Values as filed; margins = metric / revenue of the same period (calculated). Change vs prior period is calculated.
- Guards
- Gaps are shown as 'not reported', never interpolated.
- Coverage
- SEC filings only · 100 companies covered
- As of
- Oct 15, 2026
Did the growth reach the shareholder?
Per share, revenue grew 62.1%.
Source & method
- Counted
- Revenue and weighted-average diluted shares, as filed, first and last fiscal year of the range.
- Formulas
- Revenue per diluted share = revenue / diluted shares; growth = (to / from) − 1. All three changes are calculated.
- Guards
- IPO: if the start year ended more than 365 days before the first SEC filing and diluted shares then rose ≥25%, the range is hidden by default (Options → Include IPO-distorted periods). Values marked “calculated” are derived by Hollsteen, not taken verbatim from a filing.
- Coverage
- SEC filings only · 100 companies covered
- As of
- Oct 15, 2026
How profitable is it?
−5.6% operating margin, up from −10.8%.
71.7% gross margin, down from 73.3%.
Operating income: −$137M in FY2026.
Net income: −$71.2M in FY2026.
R&D grew 20% to $716M.
SG&A grew 9.0% to $1.2B.
EPS diluted: −$0.88 in FY2026.
3.7% operating margin, up from −11.0%.
73.8% gross margin, up from 71.0%.
Operating income: $28.4M in FY2027 Q2.
Net income: $40.9M in FY2027 Q2.
R&D grew 18% YoY to $214M.
SG&A grew 7.9% YoY to $327M.
EPS diluted: $0.50 in FY2027 Q2.
Source & method
- Counted
- Income statement items, as filed.
- Formulas
- Values as filed; margins = metric / revenue of the same period (calculated). Change vs prior period is calculated.
- Guards
- Gaps are shown as 'not reported', never interpolated. Values marked “calculated” are derived by Hollsteen, not taken verbatim from a filing.
- Coverage
- SEC filings only · 100 companies covered
- As of
- Oct 15, 2026
How much cash does it make, and where does it go?
Keeps $20 of every $100 as free cash.
Operating cash flow grew 236% to $505M.
Capex fell 83% to $5.0M.
Buybacks: $400M in FY2026.
Stock-based compensation grew 11% to $550M.
Free cash flow grew 95% YoY to $139M.
Operating cash flow grew 97% YoY to $142M.
Capex grew 360% YoY to $2.5M.
Buybacks fell 49% YoY to $100.0M.
Stock-based compensation grew 6.1% YoY to $149M.
Source & method
- Counted
- Cash flow statement items, as filed; free cash flow = operating cash flow − capex (calculated).
- Formulas
- Values as filed; margins = metric / revenue of the same period (calculated). Change vs prior period is calculated.
- Guards
- Gaps are shown as 'not reported', never interpolated.
- Coverage
- SEC filings only · 100 companies covered
- As of
- Oct 15, 2026
How strong is the balance sheet?
Cash: $1.1B; debt not reported.
Total debt: $0 in FY2025, the latest reported.
Interest expense fell 61% to $3.1M.
Total assets grew 9.6% to $3.8B.
Equity grew 6.1% to $3.0B.
Cash grew 55% YoY to $1.0B.
Total debt: $0 in FY2025 Q4.
Interest expense fell 37% YoY to $924K.
Total assets grew 6.7% YoY to $3.8B.
Equity grew 1.3% YoY to $3.0B.
Source & method
- Counted
- Balance sheet items at fiscal year end, as filed; total debt is derived from reported components (excl. operating leases).
- Formulas
- Values as filed; margins = metric / revenue of the same period (calculated). Change vs prior period is calculated.
- Guards
- Gaps are shown as 'not reported', never interpolated.
- Coverage
- SEC filings only · 100 companies covered
- As of
- Oct 15, 2026
Dependencies
Who does MongoDB depend on?
No customer above the disclosure threshold.
Risks
What could go wrong?
4 of 70 risk factors, one per theme.
Competition
“We currently face significant competition and expect that intense competition will continue.”
Item 1A · Risk Factors · 10-K · 0001628280-26-016799 · filed Mar 11, 2026
Security, defects and outages
“We are subject to stringent and evolving U.S. and foreign laws, regulations, rules, standards, contractual obligations, policies and other obligations particularly related to data privacy and security.”
Item 1A · Risk Factors · 10-K · 0001628280-26-016799 · filed Mar 11, 2026
Regulation and legal proceedings
“Our software incorporates third-party open source software, which could negatively affect our ability to sell our products and subject us to possible litigation.”
Item 1A · Risk Factors · 10-K · 0001628280-26-016799 · filed Mar 11, 2026
Economic conditions
“Our overall performance depends in part on worldwide economic conditions and our results of operations may vary based on the impact of changes in our industry or the global economy on us or our customers.”
Item 1A · Risk Factors · 10-K · 0001628280-26-016799 · filed Mar 11, 2026
Source and method
Short verbatim quotes from the risk factors in Item 1A, one per theme (a partial selection). Full list: 10-K.
Who’s invested
Who owns more than 5%?
BlackRock, Inc. holds 5.8%.
BlackRock, Inc.5.8%
13G/A · as of Mar 31, 2025 · filed Apr 23, 2025
Vanguard Portfolio Management LLC5.61%
13G · as of Mar 31, 2026 · filed Apr 29, 2026
Vanguard Capital Management LLC5.26%
13G · as of Mar 31, 2026 · filed Apr 30, 2026
Union Square Ventures 2008 LP29.8% (then)
13G/A · as of Dec 31, 2017 · filed Apr 19, 2018 · older than 18 months, current position unknown
Sequoia Capital Us Growth Fund Iv LP26.6% (then)
13G · as of Dec 31, 2017 · filed Feb 14, 2018 · older than 18 months, current position unknown
Source and method
Holders above 5% from Schedule 13G/13D, SEC filings only. “(then)”: reported in a filing older than 18 months; the current position is not known from SEC 13G/13D data.
19 filings reporting a stake below 5% (e.g. after selling) not listed.
13F holders and insider trades ›
Largest institutional holders, 13F, quarter ending Jun 30, 2026
BlackRock, Inc.8.5%
6.3M shares · 13F filed Aug 7, 2026 · share of 13F-reported
Vanguard Portfolio Management LLC6.0%
4.5M shares · 13F filed Aug 13, 2026 · share of 13F-reported
Fmr LLC4.9%
3.7M shares · 13F filed Aug 13, 2026 · share of 13F-reported
Vanguard Capital Management LLC4.7%
3.5M shares · 13F filed Aug 13, 2026 · share of 13F-reported
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main3.4%
2.5M shares · 13F filed Aug 14, 2026 · share of 13F-reported
871 13F filers report positions. 13F covers managers with over $100M in US equities; it is not a full shareholder list, and shares are not a percentage of shares outstanding. 1 large filing with inconsistent reported value per share left out.
Insiders, last 12 months (Form 4, open market)
0 purchases · 164 sales · $115M sold
Grants, gifts and tax withholding counted separately · window Oct 14, 2025 – Oct 14, 2026
All metrics
All metrics · 33 SEC metrics, FY2017–FY2026
Income statement 12
| Metric | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cost of revenue | ||||||||||
| D&A | ||||||||||
| G&A | ||||||||||
| Gross profit | ||||||||||
| Income taxes | ||||||||||
| Interest expense | ||||||||||
| Net income | ||||||||||
| Operating income | ||||||||||
| Research and development | ||||||||||
| Revenue | ||||||||||
| SG&A calc. | ||||||||||
| Sales & marketing | ||||||||||
Balance sheet 8
| Metric | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | ||||||||||
| Current liabilities | ||||||||||
| Equity | ||||||||||
| Equity incl. NCI | ||||||||||
| Long-term debt | not reported | not reported | ||||||||
| Total assets | ||||||||||
| Total debt calc. | not reported | not reported | ||||||||
| Total liabilities & equity | ||||||||||
Cash flow 6
| Metric | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Buybacks | ||||||||||
| Capex | ||||||||||
| Free cash flow calc. | ||||||||||
| Interest paid | ||||||||||
| Operating cash flow | ||||||||||
| Stock-based compensation | ||||||||||
Per share & shares 4
| Metric | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS basic | ||||||||||
| EPS diluted | ||||||||||
| Wtd. shares basic | ||||||||||
| Wtd. shares diluted | ||||||||||
Other 3
| Metric | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Other income (incl. interest) calc. | ||||||||||
| Pretax income | ||||||||||
| Total liabilities | ||||||||||
Method
extractive: verbatim sentences selected by rules from Item 1, 1A and 7; no AI summary; every sentence matched verbatim against the filing text. Numbers: Hollsteen SEC dataset. Every value opens its SEC source · version history of all values